調査レポートカテゴリー： Infiniti Research TechNavio, 世界

Global Plasma Therapeutics Market 2015-2019

血漿交換療法の世界市場2015-2019

◆タイトル：Global Plasma Therapeutics Market 2015-2019
◆商品コード：IRTNTR6802
◆調査・発行会社：Technavio (Infiniti Research Ltd.)
◆発行日：2015年8月5日
◆ページ数：71
◆資料形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算￥339,000見積依頼/購入/質問フォーム
Enterprise License（全社内共有可）USD4,000 ⇒換算￥452,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

 【資料の概要】

当調査レポートでは、血漿交換療法の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、血漿交換療法の世界市場規模及び予測、市場シェア、疾患別分析、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。

About plasma and plasma therapeutics
Plasma, pale yellow in color, is the component of the blood. It acts as a medium of transportation for the blood cells and other components. It carries salts and enzymes along with water and also transports nutrients, hormones, and other substances to the different parts of the body. Plasma contains immunoglobulins, clotting factors, albumin, and other components that can be used for the treatment of various diseases. The separation of plasma from the blood is done by a process known as plasmapheresis. Plasma therapeutics are utilized in the treatment of rare, life-threatening, chronic, and genetic diseases, such as immune deficiencies, pulmonary disorders, neurological disorders, shock and trauma, liver cirrhosis, and infectious diseases such as tetanus, hepatitis, and rabies.

Technavio’s analysts forecast the global plasma therapeutics market to grow at a CAGR of 12.10% over the period 2014-2019.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global plasma therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.

Technavio’s report, Global Plasma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global plasma therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• Americas
• APAC
• EMEA

[Key vendors]
• Baxter
• CSL Behring
• Grifols Therapeutics
• Octapharma

[Other prominent vendors]
• Abeona Therapeutics
• ADMA Biologics
• Amag Pharmaceuticals
• Antares Pharma
• BioDelivery Sciences
• Bio Products Laboratory
• Biota Pharmaceuticals
• Biotest Pharmaceuticals
• China Biologic Products
• Depomed
• Emergent BioSolutions
• Ethicon
• Flamel Technologies
• Kamada
• Kedrion
• King Pharmaceuticals
• Nektar Therapeutics
• OMRIX Biopharmaceuticals
• ProMetic Life Sciences
• Rockwell Medical
• The Medicines
• ZymoGenetics

[Market Driver]
• Growing demand for IVIG therapies
• For a full, detailed list, view our report

[Market challenge]
• High cost of therapy
• For a full, detailed list, view our report

[Market trend]
• Patient assistance programs
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

PART 01:Executive summary

PART 02:Scope of the report

PART 03:Market research methodology

PART 04:Introduction

PART 05:Plasma therapeutics: An overview:
Components of blood plasma
Process to derive plasma therapeutics
Clinical uses of plasma
Cost structure of plasma therapeutics

PART 06:Regulation of plasma therapeutics
Regulatory authorities

PART 07:Market landscape
Market overview
Market size and forecast
Five forces analysis

PART 08:Market segmentation by fractionation products of plasma
Human albumin
Plasma derived coagulation factors
Immunoglobulins
Hyperimmune globulins
A1PI
Global human albumin market 2014-2019
Global immunoglobulins market 2014-2019
Global A1PI market 2014-2019

PART 09:Market segmentation by disease type
Clotting disorders
Immune disorders
AATD
Others

PART 10:Geographical segmentation

PART 11:Market drivers

PART 12:Impact of drivers

PART 13:Market challenges

PART 14:Impact of drivers and challenges

PART 15:Market trends

PART 16:Vendor landscape
Competitive scenario
Market share analysis 2014
Other prominent vendors

PART 17:Key vendor analysis
Baxter International Inc.
CSL Behring
Grifols
Octapharma

PART 18:Appendix
List of abbreviation

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Composition of blood
Exhibit 03: Composition of plasma
Exhibit 04: Total collection of plasma in US 2010-2014 (in liters)
Exhibit 05: Projected fractionation capacity of manufacturing units in US and EU (millions of liter/annum)
Exhibit 06: Process of procurement and manufacturing of plasma therapeutics
Exhibit 07: Regulatory policies of plasma protein therapy lifecycle
Exhibit 08: Global plasma therapeutics market 2014-2019 ($ billions)
Exhibit 09: Five forces analysis
Exhibit 10: Global plasma therapeutics market segment by fractionation products of plasma
Exhibit 11: Global human albumin market 2014-2019 ($ millions)
Exhibit 12: Key performance indicators of global albumin market
Exhibit 13: Global immunoglobulins market 2014-2019 ($ millions)
Exhibit 14: Key performance indicators of global immunoglobulin market
Exhibit 15: Global A1PI market 2014-2019 ($ millions)
Exhibit 16: Key performance indicators of global A1PI market
Exhibit 17: Global plasma therapeutics market segment by disease type
Exhibit 18: Segmentation of global plasma therapeutics market by geography 2014
Exhibit 19: Drivers of global plasma therapeutics market
Exhibit 20: Impact of drivers
Exhibit 21: Challenges of global plasma therapeutics market
Exhibit 22: Impact of drivers and challenges
Exhibit 23: Global plasma therapeutics market share analysis 2014
Exhibit 24: YoY growth and revenue generated by plasma therapeutics 2011-2014 ($ millions)
Exhibit 25: YoY growth and revenue generate 2011-2014 ($ millions)
Exhibit 26: YoY growth and revenue of bioscience division 2011-2014 ($ millions)
Exhibit 27: Share of revenue by different divisions in 2014
Exhibit 28: YoY growth and revenue of plasma therapeutics 2011-2014 ($ millions)
Exhibit 29: Baxter International Inc. : Business segmentation
Exhibit 30: Baxter International Inc.: Revenue by business segmentation 2013
Exhibit 31: Baxter International Inc.: Revenue by geographical segmentation 2013
Exhibit 32: CSL Behring: Therapeutic areas segmentation 2013
Exhibit 33: CSL Behring: Product portfolio
Exhibit 34: CSL Behring: Geographical segmentation by revenue 2013
Exhibit 35: Grifols: Business segmentation by revenue 2013
Exhibit 36: Grifols: Business segmentation by revenue 2012 and 2013 ($ billions)
Exhibit 37: Grifols: Geographical segmentation by revenue 2013
Exhibit 38: Octapharma: Product offerings



【掲載企業】

Baxter, CSL Behring, Grifols Therapeutics, Octapharma, Abeona Therapeutics, ADMA Biologics, Amag Pharmaceuticals, Antares Pharma, BioDelivery Sciences, Bio Products Laboratory, Biota Pharmaceuticals, Biotest Pharmaceuticals, China Biologic Products, Depomed, Emergent BioSolutions, Ethicon, Flamel Technologies, Kamada, Kedrion, King Pharmaceuticals, Nektar Therapeutics, OMRIX Biopharmaceuticals, ProMetic Life Sciences, Rockwell Medical, The Medicines, ZymoGenetics

【資料のキーワード】

血漿交換療法、アルブミン、免疫グロブリン、凝固因子、A1PI、治療、凝固障害、免疫異常症、AATD

【調査方法】

一次資料による調査（業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など）及び二次資料による調査（Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど）

★調査レポート[血漿交換療法の世界市場2015-2019] (Global Plasma Therapeutics Market 2015-2019 / IRTNTR6802)販売に関する免責事項
[血漿交換療法の世界市場2015-2019] (Global Plasma Therapeutics Market 2015-2019 / IRTNTR6802)についてEメールでお問い合わせ
◆関連調査資料◆
  • 癌性疼痛治療薬の世界市場2015-2019
    IRTNTR7585 / Technavio / 2016年1月20日 / 当調査レポートでは、癌性疼痛治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、癌性疼痛治療薬の世界市場規模及び予測、種類別分析、地域別分析/市場規模、パイプライン分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Cancer Pain Therapeutics Cancer pain can be acute or chronic, depending on its stages and types. Cancer pain is caused by the tumor pressing against bones, nerves, or other organs in an individual's body. Pain control is imperative not only for people who have advanced cancer but also for those whose condition remains stable for years. Pharmaceutical interventions such as non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant pain medications are used to treat cancer pain. Technavio’s analysts forecast the global cancer pain therapeutics market to grow at a CAGR of 9.08% during the period 2016-2020. [Covered in this report]...
  • 双極性障害治療薬の世界市場2015-2019
    IRTNTR7311 / Technavio / 2015年12月16日 / 当調査レポートでは、双極性障害治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、双極性障害治療薬の世界市場規模及び予測、製品別分析、作用機序別分析、市場シェア、地域別分析/市場規模、市場の成長要因、市場の課題、製品パイプライン分析、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in for treatment. It is considered as a lifelong disease and the discontinuation of the medication can lead to relapse of the condition. Technavio's analysts...
  • 血友病A治療薬の世界市場2015-2019
    IRTNTR7382 / Technavio / 2015年9月30日 / 当調査レポートでは、血友病A治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、疾患概要、血友病A治療薬の世界市場規模及び予測、種類別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About hemophilia A Hemophilia is a rare bleeding disorder caused by deficiency of clotting factors such as VIII and IX. It is an X-linked recessive disorder, which is more prevalent in males than in females. It is estimated that it affects around 400,000 people per year. The two major types of hemophilia are A and B. Hemophilia A, also called as classical hemophilia or factor VIII deficiency hemophilia, is caused by deficiency of clotting factor VIII. It is transmitted genetically from parent to child during birth. Recombinant clotting factors or plasma-derived clotting factors are being developed for the treatment of...
  • エネルギーベース治療の世界市場2015-2019
    IRTNTR7176 / Technavio / 2015年9月16日 / 当調査レポートでは、エネルギーベース治療の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、エネルギーベース治療の世界市場規模及び予測、用途別分析、市場シェア、地域別分析、市場の成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About energy-based therapeutics Energy-based therapeutics involves the use of energy fields. These therapies include technologies such as microwave, radiofrequency, hydro-mechanical, cryotherapy, thermal, and ultrasound, which are used for either treatment or destruction of tissues to remove pathology. Energy-based therapies work on the mechanism of altering energy fields around patient's body, which can initiate healing and wellness. Technavio's analysts forecast the global energy-based therapeutics market to grow at a CAGR of 7.30% over the period 2014-2019. [Covered in this report] The report includes the present scenario and the growth prospects of the global energy-based therapeutics market for 2015-2019. The market can...
  • 網膜芽細胞腫治療薬の世界市場2015-2019
    IRTNTR6804 / Technavio / 2015年8月5日 / 当調査レポートでは、網膜芽細胞腫治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、網膜芽細胞腫治療薬の世界市場規模及び予測、治療クラス別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About retinoblastoma Cancer occurs when normal cells transform to evade the regular cell cycle process. Retinoblastoma is a rare eye cancer. It occurs in children of age less than 15 years; the disease is common in children younger than five years, especially children less than two years. The disease affects the retina and is caused by a mutation in the gene RB1. It usually appears in one eye and gradually spreads to the other. Clinically, retinoblastoma is classified into two: unilateral retinoblastoma, tumor in one eye, and bilateral retinoblastoma, tumor in both the eyes. Technavio's analysts forecast the global retinoblastoma...
  • 多形性膠芽腫治療薬の世界市場2015-2019
    IRTNTR6606 / Technavio / 2015年7月29日 / 当調査レポートでは、多形性膠芽腫治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、多形性膠芽腫治療薬の世界市場規模及び予測、種類別分析、投与経路（ROA）別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Glioblastoma Multiforme Glioblastoma multiforme is the most aggressive variant of malignant brain cancer. It has a poor prognosis with low rate of survival, a median of one year. The primary brain tumor happens due to uncontrolled cell division and developments in the brain. The tumors can be found in the glial cells or the neuron. The one which develops in the glial cells (astrocytes and oligodendrocytes) is called glioma, the commonest forms of brain tumor. Glioblastoma multiforme is the most common variant of brain tumor, and highly invasive in nature. It may turn up in the cerebrum, mostly in...
  • 血液透析製品/サービスの世界市場2015-2019
    IRTNTR5867 / Technavio / 2015年5月13日 / 当調査レポートでは、血液透析製品/サービスの世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、血液透析製品/サービスの世界市場規模及び予測、製品別分析、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About hemodialysis Hemodialysis is a procedure in which excess fluids and toxins are mechanically filtered from the blood of individuals when the kidneys are not able to function normally. It is the treatment used when there is an acute and chronic disturbance in the functioning of the kidneys. It plays a major role in improving a patient's quality of life. For hemodialysis, vascular access is needed for blood to flow out of the body to be filtered and pumped by a hemodialysis machine through a dialyzer. Hemodialysis can be performed in an in-center facility or at home. Technavio's analysts forecast...
  • 米国の医療製品包装用無菌パッケージ市場2015-2019
    IRTNTR5541 / Technavio / 2015年3月25日 / 当調査レポートでは、米国の医療製品包装用無菌パッケージ市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、米国の医療製品包装用無菌パッケージ市場規模及び予測、種類別分析、用途別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Sterile Packaging Medical products include pharmaceutical products, medical devices, surgical devices, and other healthcare-related products. Drugs/pharma products hold a major share in the Sterile Medical market. The packaging of medical products is a complex process because of their molecular and chemical structures. They need to be packaged with extremely protective and durable materials to prevent contamination. Also, the packaging materials are first sterilized before being used for packaging. The evolution of new diseases and increased health awareness have brought a transformation in the Medical Products Packaging industry. Some of the types of packaging used are bottles, vials, blisters, tubes,...
  • 2型糖尿病治療薬の世界市場2015-2019
    IRTNTR4813 / Technavio / 2014年12月10日 / 当調査レポートでは、2型糖尿病治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、2型糖尿病治療薬の世界市場規模及び予測、市場シェア、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業（ベンダー）分析などの情報をお届けいたします。...About Type 2 Diabetes Type 2 diabetes is a chronic condition, which arises due to either the inability of the body to produce enough insulin or insulin resistance, or both. Insulin is a peptide hormone produced by the Islets of Langerhans (pancreatic cells). It is produced in an immature form called preproinsulin, which is proteolytically cleaved to obtain proinsulin and then insulin. Type 2 diabetes nearly accounts for 90-95 percent of the total diabetic cases. Type 2 diabetes is usually diagnosed in middle-aged and older people; however, it can occur even during childhood. Type 2 diabetes was also known as...
  • 世界のプラズマ（Plasma）市場動向（2012-2016）
    IRTNTR2054 / Technavio / 2013年3月26日 / ...TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market. TechNavio's report, the Global Plasma Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆